{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:51:58Z","timestamp":1778187118005,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1054,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13311-020-00877-8","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T12:04:05Z","timestamp":1594123445000},"page":"1861-1877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Neuroprotective Activities of Long-Acting Granulocyte\u2013Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice"],"prefix":"10.1016","volume":"17","author":[{"given":"Katherine E.","family":"Olson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista L.","family":"Namminga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron D.","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mackenzie J.","family":"Thurston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaman","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean B.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Lee","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00877-8_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","article-title":"The scientific and clinical basis for the treatment of Parkinson disease (2009)","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00877-8_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1007\/s13311-020-00877-8_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson's disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1007\/s13311-020-00877-8_bib4","doi-asserted-by":"crossref","first-page":"a009381","DOI":"10.1101\/cshperspect.a009381","article-title":"Inflammation and adaptive immunity in Parkinson's disease","volume":"2","author":"Mosley","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1007\/s13311-020-00877-8_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2047-9158-3-25","article-title":"Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders","volume":"3","author":"Anderson","year":"2014","journal-title":"Transl Neurodegener"},{"key":"10.1007\/s13311-020-00877-8_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-020-00877-8_bib7","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1471-4159.2007.05087.x","article-title":"Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease","volume":"104","author":"Reynolds","year":"2008","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-020-00877-8_bib8","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-020-00877-8_bib9","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","article-title":"In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease","volume":"19","author":"Iannaccone","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00877-8_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00877-8_bib12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00877-8_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","article-title":"Glutathione peroxidase, glial cells and Parkinson's disease","volume":"52","author":"Damier","year":"1993","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-020-00877-8_bib14","doi-asserted-by":"crossref","first-page":"308654","DOI":"10.1155\/2014\/308654","article-title":"Evidence of inflammatory system involvement in Parkinson's disease","volume":"2014","author":"Chao","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1007\/s13311-020-00877-8_bib15","doi-asserted-by":"crossref","first-page":"e1376","DOI":"10.1371\/journal.pone.0001376","article-title":"Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons","volume":"3","author":"Benner","year":"2008","journal-title":"PLoS One"},{"key":"10.1007\/s13311-020-00877-8_bib16","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/pr9001614","article-title":"Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells","volume":"8","author":"Reynolds","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1007\/s13311-020-00877-8_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","article-title":"CD4+ regulatory and effector\/memory T-cell subsets profile motor dysfunction in Parkinson's disease","volume":"7","author":"Saunders","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1007\/s13311-020-00877-8_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1007\/s13311-020-00877-8_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.stem.2018.06.016","article-title":"Th17 cells in Parkinson's disease: the bane of the midbrain","volume":"23","author":"Bolte","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1007\/s13311-020-00877-8_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41531-017-0013-5","article-title":"Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial","volume":"3","author":"Gendelman","year":"2017","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1007\/s13311-020-00877-8_bib21","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3748\/wjg.v22.i7.2195","article-title":"Role of regulatory T cell in the pathogenesis of inflammatory bowel disease","volume":"22","author":"Yamada","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1007\/s13311-020-00877-8_bib22","doi-asserted-by":"crossref","first-page":"e89530","DOI":"10.1172\/jci.insight.89530","article-title":"ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity","volume":"2","author":"Beers","year":"2017","journal-title":"JCI Insight"},{"key":"10.1007\/s13311-020-00877-8_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2011.11.005","article-title":"Immune profiling of Alzheimer patients","volume":"242","author":"Pellicano","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-020-00877-8_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.10.009","article-title":"GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice","volume":"265","author":"Kosloski","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-020-00877-8_bib25","doi-asserted-by":"crossref","first-page":"16463","DOI":"10.1523\/JNEUROSCI.2131-15.2015","article-title":"Selective VIP receptor agonists facilitate immune transformation for dopaminergic neuroprotection in MPTP-intoxicated mice","volume":"35","author":"Olson","year":"2015","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-020-00877-8_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2018.03.009","article-title":"Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice","volume":"319","author":"Kiyota","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-020-00877-8_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clim.2008.03.509","article-title":"Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis","volume":"128","author":"Sheng","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jneuroim.2014.11.002","article-title":"Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical trauma","volume":"278","author":"Kelso","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-020-00877-8_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/STROKEAHA.110.597799","article-title":"Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke","volume":"42","author":"Sugiyama","year":"2011","journal-title":"Stroke"},{"key":"10.1007\/s13311-020-00877-8_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/eji.201847684","article-title":"GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells","volume":"49","author":"Hotta","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2011.10.010","article-title":"GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis","volume":"240-241","author":"Sheng","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-020-00877-8_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-018-0255-7","article-title":"Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease","volume":"13","author":"Schutt","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-020-00877-8_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcmgh.2015.04.005","article-title":"Granulocyte macrophage colony-stimulating factor-activated CD39(+)\/CD73(+) murine monocytes modulate intestinal inflammation via induction of regulatory T cells","volume":"1","author":"Weinhage","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1007\/s13311-020-00877-8_bib34","doi-asserted-by":"crossref","first-page":"P1572","DOI":"10.1016\/j.jalz.2017.07.735","article-title":"Interim report of a phase 2 pilot safety and efficacy trial of GM-CSF\/Leukine in mild-to-moderate Alzheimer's disease","volume":"13","author":"Potter","year":"2017","journal-title":"Alzheimer's & Dementia"},{"key":"10.1007\/s13311-020-00877-8_bib35","first-page":"606","article-title":"Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration","volume":"50","author":"Lieschke","year":"1990","journal-title":"Cancer Res"},{"key":"10.1007\/s13311-020-00877-8_bib36","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/0277-5379(90)90053-V","article-title":"The effects of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor","volume":"26","author":"Cebon","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1007\/s13311-020-00877-8_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2362.1992.tb01934.x","article-title":"Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF","volume":"22","author":"Hovgaard","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1007\/s13311-020-00877-8_bib38","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa041109","article-title":"Sargramostim in Crohn's Disease Study G: sargramostim for active Crohn's disease","volume":"352","author":"Korzenik","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1007\/s13311-020-00877-8_bib39","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1007\/BF01705031","article-title":"The side-effect profile of GM-CSF","volume":"20","author":"Stern","year":"1992","journal-title":"Infection"},{"key":"10.1007\/s13311-020-00877-8_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1007\/s13311-020-00877-8_bib41","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1073\/pnas.0400569101","article-title":"Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease","volume":"101","author":"Benner","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-020-00877-8_bib42","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1016\/j.celrep.2018.12.012","article-title":"Regulatory T cells restrain pathogenic T helper cells during skin inflammation","volume":"25","author":"Hartwig","year":"2018","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-020-00877-8_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.2830340117","article-title":"Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndrome","volume":"34","author":"Delmer","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1007\/s13311-020-00877-8_bib44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.185.4.755","article-title":"Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice","volume":"185","author":"Peters","year":"1997","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-020-00877-8_bib45","first-page":"17","article-title":"A review on laboratory liver function tests","volume":"3","author":"Gowda","year":"2009","journal-title":"Pan Afr Med J"},{"key":"10.1007\/s13311-020-00877-8_bib46","unstructured":"Busher JT: Serum albumin and globulin. In Clinical methods: the history, physical, and laboratory examinations. Edited by rd, Walker HK, Hall WD, Hurst JW. Boston; 1990"},{"key":"10.1007\/s13311-020-00877-8_bib47","doi-asserted-by":"crossref","first-page":"e12701","DOI":"10.1111\/sji.12701","article-title":"Transcription factor c-Maf is essential for IL-10 gene expression in B cells","volume":"88","author":"Liu","year":"2018","journal-title":"Scand J Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/mi.2010.8","article-title":"IL-10 production by CD4+ effector T cells: a mechanism for self-regulation","volume":"3","author":"Jankovic","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib49","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"10.1007\/s13311-020-00877-8_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1126\/sciimmunol.aao6923","article-title":"RORalpha-expressing T regulatory cells restrain allergic skin inflammation","volume":"3","author":"Malhotra","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib51","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/cmi.2015.10","article-title":"FoxP3+ regulatory T cells and their functional regulation","volume":"12","author":"Li","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature11132","article-title":"PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells","volume":"486","author":"Cipolletta","year":"2012","journal-title":"Nature"},{"key":"10.1007\/s13311-020-00877-8_bib53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cmet.2012.06.007","article-title":"Regulatory T cells expressing PPAR-gamma control inflammation in obesity","volume":"16","author":"Hamaguchi","year":"2012","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-020-00877-8_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.jcbfm.9600496","article-title":"A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF)","volume":"28","author":"Schabitz","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-020-00877-8_bib55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neures.2007.01.015","article-title":"GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins","volume":"58","author":"Huang","year":"2007","journal-title":"Neurosci Res"},{"key":"10.1007\/s13311-020-00877-8_bib56","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1089\/neu.2013.3106","article-title":"Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury","volume":"31","author":"Shultz","year":"2014","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-020-00877-8_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/brb3.11","article-title":"A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats","volume":"1","author":"Choudhury","year":"2011","journal-title":"Brain Behav"},{"key":"10.1007\/s13311-020-00877-8_bib58","doi-asserted-by":"crossref","first-page":"69347","DOI":"10.18632\/oncotarget.12469","article-title":"Neuroprotective effects of CD4+CD25+FoxP3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model","volume":"7","author":"Baek","year":"2016","journal-title":"Oncotarget"},{"key":"10.1007\/s13311-020-00877-8_bib59","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","article-title":"Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets","volume":"182","author":"Reynolds","year":"2009","journal-title":"J Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12974-018-1172-y","article-title":"URMC-099 facilitates amyloid-beta clearance in a murine model of Alzheimer's disease","volume":"15","author":"Kiyota","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"Suppl 1","key":"10.1007\/s13311-020-00877-8_bib61","first-page":"35","article-title":"Mechanisms of MPTP toxicity","volume":"13","author":"Przedborski","year":"1998","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00877-8_bib62","doi-asserted-by":"crossref","first-page":"e1006345","DOI":"10.1371\/journal.ppat.1006345","article-title":"IL-33\/ST2 pathway drives regulatory T-cell-dependent suppression of liver damage upon cytomegalovirus infection","volume":"13","author":"Popovic","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1007\/s13311-020-00877-8_bib63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuroscience.2017.11.028","article-title":"IL-33\/ST2 pathway as a rational therapeutic target for CNS diseases","volume":"369","author":"Du","year":"2018","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-020-00877-8_bib64","doi-asserted-by":"crossref","unstructured":"Liu Q, Dwyer GK, Zhao Y, Li H, et al.: IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury. JCI Insight 2019, 4.","DOI":"10.1172\/jci.insight.123919"},{"key":"10.1007\/s13311-020-00877-8_bib65","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2014-10-606830","article-title":"The IL-33\/ST2 axis augments effector T-cell responses during acute GVHD","volume":"125","author":"Reichenbach","year":"2015","journal-title":"Blood"},{"key":"10.1007\/s13311-020-00877-8_bib66","doi-asserted-by":"crossref","first-page":"e0161507","DOI":"10.1371\/journal.pone.0161507","article-title":"IL-33 receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 T cell proliferation through IL-10 and TGFbeta release","volume":"11","author":"Siede","year":"2016","journal-title":"PLoS One"},{"key":"10.1007\/s13311-020-00877-8_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-3083.2007.02035.x","article-title":"IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis","volume":"67","author":"Piao","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib68","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.4049\/jimmunol.0802978","article-title":"IL-21 mediates suppressive effects via its induction of IL-10","volume":"182","author":"Spolski","year":"2009","journal-title":"J Immunol"},{"key":"10.1007\/s13311-020-00877-8_bib69","doi-asserted-by":"crossref","unstructured":"Liu T, Zhang L, Joo D, Sun SC: NF-kappaB signaling in inflammation. Signal Transduct Target Ther 2017, 2.","DOI":"10.1038\/sigtrans.2017.23"},{"key":"10.1007\/s13311-020-00877-8_bib70","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1010238931555","article-title":"Role of transcription factor NFAT in the immune response","volume":"66","author":"Kuklina","year":"2001","journal-title":"Biochemistry (Mosc)"},{"key":"10.1007\/s13311-020-00877-8_bib71","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1016\/j.febslet.2007.10.007","article-title":"Contribution of IL-12R mediated feedback loop to Th1 cell differentiation","volume":"581","author":"Becskei","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1007\/s13311-020-00877-8_bib72","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.180.3.977","article-title":"Role of interferon regulatory factor 1 in induction of nitric oxide synthase","volume":"180","author":"Martin","year":"1994","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-020-00877-8_bib73","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.yexcr.2017.02.032","article-title":"NOR1 promotes hepatocellular carcinoma cell proliferation and migration through modulating the Notch signaling pathway","volume":"352","author":"You","year":"2017","journal-title":"Exp Cell Res"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00877-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:01:57Z","timestamp":1761807717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923012801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1878747923012801"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00877-8","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective Activities of Long-Acting Granulocyte\u2013Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00877-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}